Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab

BACKGROUND: Giant cell tumor of bone (GCTB) is a rare osteoclastogenic stromal tumor. GCTB can rarely undergo malignant transformation. This post hoc analysis evaluated and classified malignancies in patients with GCTB who received denosumab. METHODS: This analysis was conducted on patients with pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmerini, Emanuela, Seeger, Leanne L., Gambarotti, Marco, Righi, Alberto, Reichardt, Peter, Bukata, Susan, Blay, Jean-Yves, Dai, Tian, Jandial, Danielle, Picci, Piero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824947/
https://www.ncbi.nlm.nih.gov/pubmed/33482769
http://dx.doi.org/10.1186/s12885-020-07739-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824947/
https://www.ncbi.nlm.nih.gov/pubmed/33482769
http://dx.doi.org/10.1186/s12885-020-07739-8

Ejemplares similares